Jubilant Pharmova Ltd. Financials: Quarterly Results
Revenue
2136.6
Cr.
PAT
55.90
Cr.
EBITDA
189.30
Cr.
Jubilant Pharmova Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 2116.10 | 1957.80 | 1878.90 | 1915.80 | 1813.70 |
| Total Income From Operations (Cr.) | 2122.50 | 1966.40 | 1900.70 | 1928.80 | 1821.70 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 189.30 | 246.40 | 203.50 | 262.10 | 205.30 |
| P/L Before Exceptional Items & Tax (Cr.) | 133.20 | 196.20 | 154.50 | 209.40 | 149.70 |
| P/L After Tax from Ordinary Activities (Cr.) | 55.90 | 120 | 102.60 | 151.40 | 101 |
| Net Profit/Loss For the Period (Cr.) | 55.90 | 120 | 102.60 | 151.40 | 101 |
| Basic EPS | 3.52 | 7.59 | 6.49 | 9.71 | 6.37 |
FAQs
Jubilant Pharmova Ltd. announced its quarterly results for Q3 FY2026 on February 6, 2026.
In Q3 FY2026, Jubilant Pharmova Ltd. are as follows:
Revenue: ₹2136.6 crore
Net Profit: ₹55.90 crore.
For Q3 FY2026, Jubilant Pharmova Ltd. posted ₹2136.6 crore in revenue and ₹55.90 crore in net profit.
Past quarterly results for Jubilant Pharmova Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.